...
首页> 外文期刊>Pain. >Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain.
【24h】

Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain.

机译:口服持续释放吗啡对慢性非癌性疼痛患者的神经心理性能的长期影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Morphine is increasingly used in patients with chronic non-cancer pain, but a major concern associated with chronic use relates to possible cognitive side-effects. The aim of this long-term prospective study was to evaluate the cognitive impact of oral sustained release morphine in patients with non-cancer pain. A battery of neuropsychological tests to explore attention, psychomotor speed and memory was administered. The effects of morphine on pain, quality of life, mood, subjective memory impairment and side-effects were also investigated. Evaluations were performed at baseline in patients free from opioids and then after 3, 6 and 12 months. Twenty-eight patients were included: 18 received oral sustained morphine (range 40-140 mg/day), ten patients stopped morphine prematurely because of side-effects or insufficient pain relief and were followed as a control group. There was no impairment of any neuropsychological variable over time in the morphine treated patients in comparison with the control group. Two measures of information processing speed - the Stroop interference score and the digit symbol test were improved at 6 and 12 months and there were significant correlations with the pain relief and improvement of mood. Self-reported memory impairment improved notably in responders to morphine. Morphine induced persisting effects on pain, and to a lesser extent on quality of life and mood. The visual analog scale score for side-effects increased at 12 months and essentially consisted of gastrointestinal disorders. This study demonstrates that 12 months treatment with oral morphine does not disrupt cognitive functioning in patients with chronic non-cancer pain and instead results in moderate improvement of some aspects of cognitive functioning, as a consequence of the pain relief and concomitant improvement of well-being and mood.
机译:吗啡在患有慢性非癌性疼痛的患者中越来越多地使用,但与长期使用相关的主要关注点涉及可能的认知副作用。这项长期前瞻性研究的目的是评估口服持续释放吗啡对非癌性疼痛患者的认知影响。进行了一系列神经心理学测试,以探索注意力,心理运动速度和记忆力。还研究了吗啡对疼痛,生活质量,情绪,主观记忆障碍和副作用的影响。对无阿片类药物的患者在基线时进行评估,然后在3、6和12个月后进行评估。包括28例患者:18例接受口服持续吗啡(范围40-140 mg /天),10例因副作用或疼痛缓解不足而提前停用吗啡,并作为对照组。与对照组相比,吗啡治疗的患者随时间推移没有任何神经心理学变量的损害。信息处理速度的两个指标-Stroop干扰评分和数字符号测试在6和12个月时有所改善,并且与缓解疼痛和改善情绪有显着相关性。自我报告的记忆障碍在吗啡应答者中明显改善。吗啡可引起持续的疼痛影响,并在较小程度上影响生活质量和情绪。副作用的视觉模拟量表评分在12个月时增加,并且基本上由胃肠道疾病组成。这项研究表明,口服吗啡治疗12个月不会破坏慢性非癌性疼痛患者的认知功能,而是会减轻疼痛并伴随改善幸福感,从而导致认知功能某些方面的适度改善和心情。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号